Free Trial
LON:N4P

N4 Pharma (N4P) Share Price, News & Analysis

N4 Pharma logo
GBX 0.50 +0.05 (+11.11%)
As of 08/1/2025 12:04 PM Eastern

About N4 Pharma Stock (LON:N4P)

Key Stats

Today's Range
0.40
0.50
50-Day Range
0.35
0.50
52-Week Range
0.35
0.80
Volume
412,702 shs
Average Volume
2.00 million shs
Market Capitalization
£2.15 million
P/E Ratio
N/A
Dividend Yield
3.12%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive N4P Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for N4 Pharma and its competitors with MarketBeat's FREE daily newsletter.

N4P Stock News Headlines

N4 Pharma PLC reports change in major holdings
N4 Pharma PLC
Ex-Hedge Fund Manager Uncovers $100 Trillion Land Shift
Trump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to unlock federal lands, oil reserves, and buried minerals... all for profit. Trump's team is already executing the orders... and Wall Street legend Whitney Tilson is stepping forward to show you how to position before the deadline.
N4 Pharma Plc Share Chat (N4P)
N4 Pharma PLC (N4P.AQ)
See More Headlines

N4P Stock Analysis - Frequently Asked Questions

N4 Pharma's stock was trading at GBX 0.54 at the beginning of 2025. Since then, N4P shares have decreased by 6.5% and is now trading at GBX 0.50.

N4 Pharma Plc (LON:N4P) posted its earnings results on Monday, June, 9th. The company reported ($0.31) earnings per share for the quarter. N4 Pharma had a negative trailing twelve-month return on equity of 90.68% and a negative net margin of 18,399.86%.

Shares of N4P stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that N4 Pharma investors own include 4D pharma (DDDD), Active Energy Group (AEG), B&M European Value Retail (BME), BP (BP), Coats Group (COA), EQTEC (EQT) and genedrive (GDR).

Company Calendar

Last Earnings
6/09/2025
Today
8/02/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
LON:N4P
CIK
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.35)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£1.63 million
Net Margins
-18,399.86%
Pretax Margin
N/A
Return on Equity
-90.68%
Return on Assets
-56.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
22.73
Quick Ratio
7.28

Sales & Book Value

Annual Sales
£8.84 thousand
Price / Sales
243.55
Cash Flow
GBX 0.22 per share
Price / Cash Flow
2.25
Book Value
GBX 0.45 per share
Price / Book
1.12

Miscellaneous

Outstanding Shares
430,669,091
Free Float
N/A
Market Cap
£2.15 million
Optionable
Not Optionable
Beta
-0.37
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (LON:N4P) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners